00http://fasb.org/us-gaap/2023#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesCurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent0001039065--06-302023Q1false1675577216987842http://fasb.org/us-gaap/2023#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesCurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent0001039065us-gaap:CommonStockMember2023-09-300001039065us-gaap:CommonStockMember2022-09-300001039065us-gaap:RetainedEarningsMember2023-09-300001039065us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-09-300001039065us-gaap:RetainedEarningsMember2023-06-300001039065us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-300001039065us-gaap:RetainedEarningsMember2022-09-300001039065us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-09-300001039065us-gaap:RetainedEarningsMember2022-06-300001039065us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-06-300001039065us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2023-09-300001039065us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2023-06-300001039065us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2022-09-300001039065us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2022-06-300001039065us-gaap:EmployeeStockOptionMember2023-06-300001039065osis:ShareBasedEmployeeCompensationPlansMember2023-09-300001039065us-gaap:RestrictedStockUnitsRSUMember2023-06-300001039065osis:PerformanceBasedRestrictedStockUnitsMember2023-07-012023-09-300001039065osis:PerformanceBasedRestrictedStockUnitsMember2022-07-012022-09-3000010390652023-10-012023-09-300001039065us-gaap:FacilityClosingMember2023-09-300001039065us-gaap:EmployeeSeveranceMember2023-09-300001039065us-gaap:AcquisitionRelatedCostsMember2023-09-300001039065osis:ChargesRelatedToLitigationMember2023-09-300001039065us-gaap:FacilityClosingMember2023-06-300001039065us-gaap:EmployeeSeveranceMember2023-06-300001039065us-gaap:AcquisitionRelatedCostsMember2023-06-300001039065osis:ChargesRelatedToLitigationMember2023-06-300001039065us-gaap:LeaseholdImprovementsMember2023-09-300001039065us-gaap:LandMember2023-09-300001039065us-gaap:FurnitureAndFixturesMember2023-09-300001039065us-gaap:EquipmentMember2023-09-300001039065us-gaap:ConstructionInProgressMember2023-09-300001039065us-gaap:ComputerSoftwareIntangibleAssetMember2023-09-300001039065us-gaap:ComputerEquipmentMember2023-09-300001039065us-gaap:BuildingAndBuildingImprovementsMember2023-09-300001039065osis:ComputerSoftwareImplementationInProcessMember2023-09-300001039065us-gaap:LeaseholdImprovementsMember2023-06-300001039065us-gaap:LandMember2023-06-300001039065us-gaap:FurnitureAndFixturesMember2023-06-300001039065us-gaap:EquipmentMember2023-06-300001039065us-gaap:ConstructionInProgressMember2023-06-300001039065us-gaap:ComputerSoftwareIntangibleAssetMember2023-06-300001039065us-gaap:ComputerEquipmentMember2023-06-300001039065us-gaap:BuildingAndBuildingImprovementsMember2023-06-300001039065osis:ComputerSoftwareImplementationInProcessMember2023-06-300001039065us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-07-012023-09-300001039065us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-07-012022-09-300001039065us-gaap:OperatingSegmentsMemberosis:SecurityDivisionMember2023-07-012023-09-300001039065us-gaap:OperatingSegmentsMemberosis:OptoelectronicsAndManufacturingDivisionMember2023-07-012023-09-300001039065us-gaap:OperatingSegmentsMemberosis:HealthcareDivisionMember2023-07-012023-09-300001039065us-gaap:IntersegmentEliminationMember2023-07-012023-09-300001039065us-gaap:CorporateNonSegmentMember2023-07-012023-09-300001039065us-gaap:OperatingSegmentsMemberosis:SecurityDivisionMember2022-07-012022-09-300001039065us-gaap:OperatingSegmentsMemberosis:OptoelectronicsAndManufacturingDivisionMember2022-07-012022-09-300001039065us-gaap:OperatingSegmentsMemberosis:HealthcareDivisionMember2022-07-012022-09-300001039065us-gaap:IntersegmentEliminationMember2022-07-012022-09-300001039065us-gaap:CorporateNonSegmentMember2022-07-012022-09-300001039065us-gaap:CorporateMember2023-07-012023-09-300001039065us-gaap:CorporateMember2022-07-012022-09-300001039065osis:OtherOperationalEfficiencyActivitiesMember2022-07-012022-09-300001039065osis:HealthcareDivisionMember2022-07-012022-09-300001039065srt:MinimumMemberus-gaap:RevolvingCreditFacilityMember2023-07-012023-09-300001039065srt:MaximumMemberus-gaap:RevolvingCreditFacilityMember2023-07-012023-09-300001039065us-gaap:RevolvingCreditFacilityMember2023-07-012023-09-300001039065srt:MinimumMemberus-gaap:RevolvingCreditFacilityMember2021-12-310001039065us-gaap:RevolvingCreditFacilityMember2021-12-310001039065osis:LettersOfCreditSubFacilityMember2021-12-310001039065us-gaap:RevolvingCreditFacilityMember2023-09-300001039065osis:TermLoanMember2023-09-300001039065us-gaap:LineOfCreditMember2023-09-300001039065osis:LettersOfCreditSubFacilityMember2023-09-300001039065osis:ConvertibleSeniorNotesDue2022Member2023-07-012023-09-300001039065osis:CreditFacilityAndDelayedDrawTermLoanMember2023-07-012023-09-300001039065osis:CreditFacilityAndDelayedDrawTermLoanMember2022-07-012022-09-300001039065us-gaap:TrademarksMember2023-09-300001039065us-gaap:InProcessResearchAndDevelopmentMember2023-09-300001039065us-gaap:TrademarksMember2023-06-300001039065us-gaap:InProcessResearchAndDevelopmentMember2023-06-300001039065osis:SecurityDivisionMember2023-07-012023-09-300001039065osis:OptoelectronicsAndManufacturingDivisionMember2023-07-012023-09-300001039065osis:HealthcareDivisionMember2023-07-012023-09-300001039065osis:SecurityDivisionMember2023-09-300001039065osis:OptoelectronicsAndManufacturingDivisionMember2023-09-300001039065osis:HealthcareDivisionMember2023-09-300001039065osis:SecurityDivisionMember2023-06-300001039065osis:OptoelectronicsAndManufacturingDivisionMember2023-06-300001039065osis:HealthcareDivisionMember2023-06-300001039065srt:MinimumMemberus-gaap:SoftwareAndSoftwareDevelopmentCostsMember2023-09-300001039065srt:MaximumMemberus-gaap:SoftwareAndSoftwareDevelopmentCostsMember2023-09-300001039065us-gaap:SoftwareAndSoftwareDevelopmentCostsMember2023-09-300001039065us-gaap:PatentsMember2023-09-300001039065us-gaap:DevelopedTechnologyRightsMember2023-09-300001039065osis:CustomerRelationshipsOrderOrProductionBacklogMember2023-09-300001039065us-gaap:SoftwareAndSoftwareDevelopmentCostsMember2023-06-300001039065us-gaap:PatentsMember2023-06-300001039065us-gaap:DevelopedTechnologyRightsMember2023-06-300001039065osis:CustomerRelationshipsOrderOrProductionBacklogMember2023-06-300001039065us-gaap:RestrictedStockUnitsRSUMember2023-07-012023-09-300001039065us-gaap:EmployeeStockOptionMember2023-07-012023-09-300001039065us-gaap:RestrictedStockUnitsRSUMember2023-09-300001039065us-gaap:EmployeeStockOptionMember2023-09-300001039065us-gaap:ForeignExchangeForwardMember2023-09-300001039065us-gaap:ForeignExchangeForwardMember2023-06-300001039065us-gaap:InterestRateSwapMember2023-09-300001039065us-gaap:InterestRateSwapMember2023-06-300001039065osis:ConvertibleSeniorNotesDue2022Member2017-02-280001039065srt:MinimumMemberus-gaap:RevolvingCreditFacilityMemberosis:LiborMember2023-07-012023-09-300001039065srt:MaximumMemberus-gaap:RevolvingCreditFacilityMemberosis:LiborMember2023-07-012023-09-300001039065us-gaap:RevolvingCreditFacilityMemberosis:LiborMember2023-07-012023-09-300001039065us-gaap:ServiceMember2023-07-012023-09-300001039065us-gaap:ProductMember2023-07-012023-09-300001039065us-gaap:ServiceMember2022-07-012022-09-300001039065us-gaap:ProductMember2022-07-012022-09-300001039065osis:OneInternationalCustomerMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2023-07-012023-09-300001039065osis:OneCustomerMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2023-07-012023-09-300001039065osis:OneCustomerMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2022-07-012023-06-300001039065osis:OneInternationalCustomerMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2022-07-012022-09-3000010390652022-09-3000010390652022-06-300001039065us-gaap:SoftwareAndSoftwareDevelopmentCostsMember2023-07-012023-09-300001039065us-gaap:SoftwareAndSoftwareDevelopmentCostsMember2022-07-012022-09-300001039065osis:OptoelectronicsAndManufacturingDivisionMember2023-07-012023-09-300001039065osis:SecurityDivisionMember2022-07-012022-09-300001039065osis:OptoelectronicsAndManufacturingDivisionMember2022-07-012022-09-300001039065us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2023-09-300001039065us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2023-06-300001039065osis:PrivatelyHeldProviderOfRadiationTechnologyMember2023-10-310001039065us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember2023-09-300001039065osis:AprivatelyheldproviderofengineeringandcontractmanufacturingsolutionsMember2023-04-300001039065osis:PrivatelyHeldProviderOfTrainingSoftwareAndSolutionsMember2023-02-280001039065osis:PrivatelyHeldProviderOfRadiationTechnologyMember2023-10-012023-10-310001039065osis:AprivatelyheldproviderofengineeringandcontractmanufacturingsolutionsMember2023-04-012023-04-300001039065osis:PrivatelyHeldProviderOfTrainingSoftwareAndSolutionsMember2023-02-012023-02-280001039065osis:ProviderOfBaggageAndParcelInspectionSystemsMember2022-12-012022-12-310001039065osis:PrivatelyHeldProviderOfTrainingSoftwareAndSolutionsMember2022-08-012022-08-310001039065osis:SecurityDivisionMember2023-07-012023-09-300001039065osis:OtherOperationalEfficiencyActivitiesMember2023-07-012023-09-300001039065us-gaap:OperatingSegmentsMemberosis:SecurityDivisionMember2023-09-300001039065us-gaap:OperatingSegmentsMemberosis:OptoelectronicsAndManufacturingDivisionMember2023-09-300001039065us-gaap:OperatingSegmentsMemberosis:HealthcareDivisionMember2023-09-300001039065us-gaap:IntersegmentEliminationMember2023-09-300001039065us-gaap:CorporateNonSegmentMember2023-09-300001039065us-gaap:OperatingSegmentsMemberosis:SecurityDivisionMember2023-06-300001039065us-gaap:OperatingSegmentsMemberosis:OptoelectronicsAndManufacturingDivisionMember2023-06-300001039065us-gaap:OperatingSegmentsMemberosis:HealthcareDivisionMember2023-06-300001039065us-gaap:IntersegmentEliminationMember2023-06-300001039065us-gaap:CorporateNonSegmentMember2023-06-300001039065osis:ConvertibleSeniorNotesDue2022Member2022-07-012022-09-300001039065us-gaap:SellingGeneralAndAdministrativeExpensesMember2023-07-012023-09-300001039065us-gaap:ResearchAndDevelopmentExpenseMember2023-07-012023-09-300001039065us-gaap:CostOfSalesMember2023-07-012023-09-300001039065us-gaap:SellingGeneralAndAdministrativeExpensesMember2022-07-012022-09-300001039065us-gaap:ResearchAndDevelopmentExpenseMember2022-07-012022-09-300001039065us-gaap:CostOfSalesMember2022-07-012022-09-300001039065us-gaap:RetainedEarningsMember2023-07-012023-09-300001039065us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2023-07-012023-09-300001039065us-gaap:RetainedEarningsMember2022-07-012022-09-300001039065us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2022-07-012022-09-300001039065srt:MinimumMemberosis:PerformanceBasedRestrictedStockUnitsMember2023-07-012023-09-300001039065srt:MaximumMemberosis:PerformanceBasedRestrictedStockUnitsMember2023-07-012023-09-300001039065us-gaap:RestrictedStockUnitsRSUMemberosis:ShareBasedEmployeeCompensationPlansMember2023-07-012023-09-300001039065us-gaap:FacilityClosingMember2023-07-012023-09-300001039065us-gaap:EmployeeSeveranceMember2023-07-012023-09-300001039065us-gaap:AcquisitionRelatedCostsMember2023-07-012023-09-300001039065osis:ChargesRelatedToLitigationMember2023-07-012023-09-300001039065us-gaap:RevolvingCreditFacilityMember2021-12-012021-12-310001039065srt:MaximumMemberus-gaap:RevolvingCreditFacilityMember2021-12-310001039065us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-09-300001039065us-gaap:FairValueMeasurementsRecurringMember2023-09-300001039065us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-06-300001039065us-gaap:FairValueMeasurementsRecurringMember2023-06-300001039065srt:ChiefExecutiveOfficerMemberus-gaap:DeferredBonusMember2017-12-012017-12-310001039065srt:ChiefExecutiveOfficerMemberus-gaap:DeferredBonusMember2017-12-310001039065osis:ConvertibleSeniorNotesDue2022Member2022-09-0100010390652023-09-3000010390652023-06-3000010390652022-07-012023-06-3000010390652022-07-012022-09-300001039065osis:VictorSzeMember2023-09-300001039065osis:VictorSzeMember2023-07-012023-09-3000010390652023-10-2400010390652023-07-012023-09-30xbrli:sharesiso4217:USDxbrli:pureosis:customeriso4217:USDxbrli:sharesosis:segment

Table of Contents

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2023

OR

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from              to             

Commission File Number 000-23125

Graphic

OSI SYSTEMS, INC.

(Exact name of registrant as specified in its charter)

Delaware

    

33-0238801

(State or other jurisdiction of
incorporation or organization)

(I.R.S. Employer
Identification No.)

12525 Chadron Avenue

Hawthorne, California 90250

(Address of principal executive offices) (Zip Code)

(310) 978-0516

(Registrant’s telephone number, including area code)

N/A

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

    

Trading Symbol(s)

    

Name of each exchange on which registered

Common Stock, $0.001 par value

OSIS

The Nasdaq Global Select Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  No 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes No 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer 

   

Accelerated filer 

Non-accelerated filer 

Smaller reporting company 

Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  No 

As of October 24, 2023, there were 16,987,842 shares of the registrant’s common stock outstanding.

Table of Contents

OSI SYSTEMS, INC.

INDEX

PAGE

PART I — FINANCIAL INFORMATION

3

Item 1 —

Financial Statements (Unaudited)

3

Condensed Consolidated Balance Sheets at June 30, 2023 and September 30, 2023

3

Condensed Consolidated Statements of Operations for the three months ended September 30, 2022 and 2023

4

Condensed Consolidated Statements of Comprehensive Income for the three months ended September 30, 2022 and 2023

5

Condensed Consolidated Statements of Stockholders’ Equity for the three months ended September 30, 2022 and 2023

6

Condensed Consolidated Statements of Cash Flows for the three months ended September 30, 2022 and 2023

7

Notes to Condensed Consolidated Financial Statements

8

Item 2 —

Management’s Discussion and Analysis of Financial Condition and Results of Operations

21

Item 3 —

Quantitative and Qualitative Disclosures about Market Risk

26

Item 4 —

Controls and Procedures

26

PART II — OTHER INFORMATION

28

Item 1 —

Legal Proceedings

28

Item 1A —

Risk Factors

28

Item 2 —

Unregistered Sales of Equity Securities and Use of Proceeds

28

Item 3 —

Defaults Upon Senior Securities

28

Item 4 —

Mine Safety Disclosures

28

Item 5 —

Other Information

28

Item 6 —

Exhibits

29

Signatures

30

2

Table of Contents

PART I—FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

OSI SYSTEMS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)

(amounts in thousands, except share amounts and par value)

June 30, 

September 30, 

    

2023

    

2023

ASSETS

CURRENT ASSETS:

Cash and cash equivalents

$

76,750

$

82,591

Accounts receivable, net

 

380,845

323,769

Inventories

 

338,008

418,797

Prepaid expenses and other current assets

 

44,300

46,942

Total current assets

 

839,903

872,099

Property and equipment, net

 

108,933

109,174

Goodwill

 

349,505

348,411

Intangible assets, net

 

140,857

140,211

Other assets

 

116,488

118,557

Total assets

$

1,555,686

$

1,588,452

LIABILITIES AND STOCKHOLDERS’ EQUITY

CURRENT LIABILITIES:

Bank lines of credit

$

215,000

$

235,000

Current portion of long-term debt

 

8,076

8,134

Accounts payable

 

139,011

164,422

Accrued payroll and related expenses

 

51,243

44,430

Advances from customers

 

21,250

31,949

Other accrued expenses and current liabilities

 

137,114

127,693

Total current liabilities

 

571,694

611,628

Long-term debt

 

136,491

134,746

Deferred income taxes

 

6,571

6,868

Other long-term liabilities

 

114,765

110,753

Total liabilities

 

829,521

863,995

Commitments and contingencies (Note 10)

STOCKHOLDERS’ EQUITY:

Preferred stock, $0.001 par value— 10,000,000 shares authorized; no shares issued or outstanding

 

Common stock, $0.001 par value—100,000,000 shares authorized; issued and outstanding, 16,755,772 shares at June 30, 2023 and 16,987,842 shares at September 30, 2023

 

9,835

17

Retained earnings

 

735,957

745,955

Accumulated other comprehensive loss

 

(19,627)

(21,515)

Total stockholders’ equity

 

726,165

724,457

Total liabilities and stockholders’ equity

$

1,555,686

$

1,588,452

See accompanying notes to condensed consolidated financial statements.

3

Table of Contents

OSI SYSTEMS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

(amounts in thousands, except per share data)

Three Months Ended September 30, 

    

2022

    

2023

Net revenues:

Products

$

196,954

$

199,709

Services

 

71,117

79,501

Total net revenues

 

268,071

279,210

Cost of goods sold:

Products

 

143,369

136,983

Services

 

37,205

43,482

Total cost of goods sold

 

180,574

180,465

Gross profit

 

87,497

98,745

Operating expenses:

Selling, general and administrative

 

53,438

59,798

Research and development

 

14,540

15,922

Impairment, restructuring and other charges, net

 

1,219

466

Total operating expenses

 

69,197

76,186

Income from operations

 

18,300

22,559

Interest and other expense, net

 

(3,432)

(5,748)

Income before income taxes

 

14,868

16,811

Provision for income taxes

 

(3,633)

(3,932)

Net income

$

11,235

$

12,879

Earnings per share:

Basic

$

0.66

$

0.77

Diluted

$

0.65

$

0.75

Shares used in per share calculation:

Basic

 

16,924

16,825

Diluted

 

17,180

17,175

See accompanying notes to condensed consolidated financial statements.

4

Table of Contents

OSI SYSTEMS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)

(amounts in thousands)

    

Three Months Ended September 30, 

    

2022

    

2023

Net income

$

11,235

$

12,879

Other comprehensive loss:

Foreign currency translation adjustment, net of tax

 

(9,792)

(3,172)

Net unrealized gain on derivatives, net of tax

3,540

1,147

Other, net of tax

333

137

Other comprehensive loss

(5,919)

(1,888)

Comprehensive income

$

5,316

$

10,991

See accompanying notes to condensed consolidated financial statements.

5

Table of Contents

OSI SYSTEMS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (UNAUDITED)

(amounts in thousands, except share data)

Three Months Ended September 30, 2022

Accumulated

Common Stock

Other

    

Number of

    

    

Retained

    

Comprehensive

    

    

Shares

    

Amount

    

Earnings

    

Loss

    

Total

Balance—June 30, 2022

 

16,870,050

$

17

$

663,869

$

(25,462)

$

638,424

Exercise of stock options

 

2,919

194

194

Vesting of RSUs

 

286,119

Shares issued under employee stock purchase program

 

28,603

1,969

1,969

Stock-based compensation expense

 

7,177

7,177

Repurchase of common stock

(208,427)

(208)

(17,079)

(17,287)

Taxes paid related to net share settlement of equity awards

 

(125,111)

(9,132)

(2,008)

(11,140)

Net income

 

11,235

11,235

Other comprehensive loss

 

(5,919)

(5,919)

Balance—September 30, 2022

16,854,153

$

17

$

656,017

$

(31,381)

$

624,653

Three Months Ended September 30, 2023

Accumulated

Common Stock

Other

    

Number of

    

    

Retained

    

Comprehensive

    

    

Shares

    

Amount

    

Earnings

    

Loss

    

Total

Balance—June 30, 2023

16,755,772

$

9,835

$

735,957

$

(19,627)

$

726,165

Exercise of stock options

4,752

420

420

Vesting of RSUs

363,820

Shares issued under employee stock purchase program

29,813

2,031

2,031

Stock-based compensation expense

7,089

7,089

Taxes paid related to net share settlement of equity awards

(166,315)

(19,358)

(2,881)

(22,239)

Net income

12,879

12,879

Other comprehensive loss

(1,888)

(1,888)

Balance—September 30, 2023

 

16,987,842

$

17

$

745,955

$

(21,515)

$

724,457

6

Table of Contents

OSI SYSTEMS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

(amounts in thousands)

Three Months Ended September 30, 

    

2022

    

2023

CASH FLOWS FROM OPERATING ACTIVITIES

    

Net income

$

11,235

$

12,879

Adjustments to reconcile net income to net cash provided by operating activities, net of effects from acquisitions:

Depreciation and amortization

 

9,541

9,568

Stock-based compensation expense

 

7,177

7,089

Recovery of losses on accounts receivable

(1,675)

(433)

Deferred income taxes

121

208

Amortization of debt discount and issuance costs

 

196

Other

 

7

42

Changes in operating assets and liabilities—net of business acquisitions:

Accounts receivable

 

(5,376)

55,868

Inventories

 

(29,966)

(82,035)

Prepaid expenses and other assets

 

(8,587)

(7,605)

Accounts payable

 

20,000

25,851

Accrued payroll and related expenses

(10,987)

(6,606)

Advances from customers

 

10,133

10,770

Deferred revenue

19,231

(7,142)

Other

 

(3,808)

(1,310)

Net cash provided by operating activities

 

17,242

17,144

CASH FLOWS FROM INVESTING ACTIVITIES

Acquisition of property and equipment

 

(3,281)

(5,239)

Proceeds from sale of property and equipment

92

44

Purchases of certificates of deposit

(73)

(2,068)

Proceeds from maturities of certificates of deposit

1,839

Acquisition of businesses, net of cash acquired

 

(1,871)

Payments for intangible and other assets

 

(3,944)

(4,154)

Net cash used in investing activities

 

(9,077)

(9,578)

CASH FLOWS FROM FINANCING ACTIVITIES

Net borrowings on bank lines of credit

 

155,000

20,000

Proceeds from long-term debt

 

100,307

394

Payments on long-term debt

 

(242,479)

(2,073)

Proceeds from exercise of stock options and employee stock purchase plan

 

2,163

2,451

Payments of contingent consideration

(415)

(383)

Repurchases of common stock

 

(17,287)

Taxes paid related to net share settlement of equity awards

 

(11,140)

(22,239)

Net cash used in financing activities

 

(13,851)

(1,850)

Effect of exchange rate changes on cash

 

(4,526)

125

Net change in cash and cash equivalents

 

(10,212)

5,841

Cash and cash equivalents—beginning of period

 

64,202

76,750

Cash and cash equivalents—end of period

$

53,990

$

82,591

Supplemental disclosure of cash flow information:

Cash paid, net during the period for:

Interest

$

3,856

$

5,455

Income taxes

$

7,235

$

6,795

See accompanying notes to condensed consolidated financial statements.

7

Table of Contents

OSI SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

1. Basis of Presentation

The condensed consolidated financial statements include the accounts of OSI Systems, Inc. and our subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. The condensed consolidated financial statements have been prepared by management in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and in conjunction with the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures required for annual financial statements have been condensed or excluded in accordance with SEC rules and regulations and GAAP applicable to interim unaudited financial statements. Accordingly, the condensed consolidated financial statements do not include all of the information and footnotes required by GAAP for audited annual financial statements. In the opinion of management, the condensed consolidated financial statements reflect all adjustments of a normal and recurring nature that are considered necessary for a fair presentation of the results for the interim periods presented. These unaudited condensed consolidated financial statements and the accompanying notes should be read in conjunction with the audited consolidated financial statements and accompanying notes included in our Annual Report on Form 10-K for the fiscal year ended June 30, 2023 filed with the SEC. The results of operations for the three months ended September 30, 2023 are not necessarily indicative of the operating results to be expected for the full 2024 fiscal year or any future periods.

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of sales, costs of sales and expenses during the reporting period. The most significant of these estimates and assumptions for our company relate to contract revenue, fair values of assets acquired and liabilities assumed in business combinations, values for inventories reported at lower of cost or net realizable value, stock-based compensation expense, income taxes, accrued warranty costs, contingent consideration, allowance for doubtful accounts, and the recoverability, useful lives and valuation of recorded amounts of long-lived assets, identifiable intangible assets and goodwill. Changes in estimates are reflected in the periods during which they become known. Due to the inherent uncertainty involved in making estimates, our actual amounts reported in future periods could differ materially from these estimates.

Earnings Per Share Computations

We compute basic earnings per share by dividing net income available to common stockholders by the weighted average number of common shares outstanding during the period. We compute diluted earnings per share by dividing net income available to common stockholders by the sum of the weighted average number of common shares and dilutive potential common shares outstanding during the period. Potential common shares consist of the shares issuable upon the exercise of stock options and restricted stock unit awards under the treasury stock method.

The following table sets forth the computation of basic and diluted earnings per share (in thousands, except per share amounts):

    

Three Months Ended September 30, 

2022

    

2023

Net income available to common stockholders

$

11,235

$

12,879

Weighted average shares outstanding—basic

 

16,924

16,825

Dilutive effect of equity awards

 

256

350

Weighted average shares outstanding—diluted

 

17,180

17,175

Basic earnings per share

$

0.66

$

0.77

Diluted earnings per share

$

0.65

$

0.75

Shares excluded from diluted earnings per share due to their anti-dilutive effect

26

8

8

Table of Contents

Cash and Cash Equivalents

We consider all highly liquid investments with maturities of three months or less as of the acquisition date to be cash equivalents.

Our cash and cash equivalents totaled $82.6 million at September 30, 2023. Of this amount, approximately 91% was held by our foreign subsidiaries and subject to repatriation tax considerations.  These foreign funds were held primarily by our subsidiaries in the United Kingdom, Qatar, Singapore, India, Malaysia and Canada, and to a lesser extent in Indonesia, Australia, Germany, Mexico and Egypt among other countries. We have cash holdings in financial institutions that exceed insured limits for such financial institutions; however, we mitigate this risk by utilizing international financial institutions of high credit quality.

Fair Value of Financial Instruments

Our financial instruments consist primarily of cash and cash equivalents, insurance company contracts, accounts receivable, accounts payable, debt instruments, an interest rate swap contract and foreign currency forward contracts. The carrying values of financial instruments, other than long-term debt instruments and the interest rate swap contract, are representative of their fair values due to their short-term maturities. The carrying values of our long-term debt instruments are considered to approximate their fair values because the interest rates of these instruments are variable or comparable to current rates for financing available to us. The fair values of our foreign currency forward contracts were not significant as of June 30, 2023 and September 30, 2023.

Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The “Level 1” category includes assets and liabilities at quoted prices in active markets for identical assets and liabilities. The “Level 2” category includes assets and liabilities from observable inputs other than quoted market prices. The “Level 3” category includes assets and liabilities for which valuation techniques are unobservable and significant to the fair value measurement. Our contingent payment obligations related to acquisitions, which are further discussed in Note 10 to the condensed consolidated financial statements, are in the “Level 3” category for valuation purposes.

The fair values of our financial assets and liabilities are categorized as follows (in thousands):

    

June 30, 2023

    

September 30, 2023

    

Level 1

    

Level 2

    

Level 3

    

Total

    

Level 1

    

Level 2

    

Level 3

    

Total

Assets—Insurance company contracts

$

$

47,181

$

$

47,181

$

$

47,508

$

$

47,508

Assets – Interest rate swap contract

$

$

5,369

$

$

5,369

$

$

6,826

$

$

6,826

Liabilities—Contingent consideration

$

$

$

21,181

$

21,181

$

$

$

19,784

$

19,784

Derivative Instruments and Hedging Activity

Our use of derivatives consists of foreign currency forward contracts and an interest rate swap contract. The foreign currency forward contracts are utilized to partially mitigate certain balance sheet exposures or used as a net investment hedge to protect against potential changes resulting from short-term foreign currency fluctuations. These contracts have original maturities of up to three months. We also manage our risk to changes in interest rates using derivative instruments. We use fixed interest rate swaps to effectively convert a portion of the variable interest rate payments to fixed interest rate payments. We do not use hedging instruments for speculative purposes.

The net gains or losses from our foreign currency forward contracts, which are not designated as hedge instruments, are reported in the consolidated statements of operations, and the amounts reported for the three months ended September 30, 2022 and 2023 were not significant.  The fair value of our foreign currency forward contracts is estimated using a standard valuation model and market-based observable inputs over the contractual term. Unrealized gains are recognized as assets and unrealized losses are recognized as liabilities.  As of June 30, 2023 and September 30, 2023, we held foreign currency forward contracts with notional amounts totaling $21.6 million and $25.6 million, respectively. Unrealized gains and losses from our foreign currency forward contracts as of June 30, 2023 and September 30, 2023 were not significant.

9

Table of Contents

The interest rate swap agreement was entered into to improve the predictability of cash flows from interest payments related to our variable, Secured Overnight Financing Rate (“SOFR”) based debt. The interest rate swap matures in December 2026. The interest rate swap is considered an effective cash flow hedge, and as a result, the net gains or losses on such instrument are reported as a component of other comprehensive income in the consolidated financial statements and are reclassified as net income when the underlying hedged interest expense impacts earnings. A qualitative and quantitative assessment over the hedge effectiveness is performed on a quarterly basis, unless facts and circumstances indicate that the hedge may no longer be highly effective.

As of June 30, 2023 and September 30, 2023, the notional amount of the derivative instruments designated as an interest rate swap hedge was $175 million. The fair value of the interest rate swap contract as of as of June 30, 2023 and September 30, 2023 is recorded in Other assets within the consolidated balance sheet.

The effect of the cash flow hedges on other comprehensive income (loss) and earnings for the periods presented was as follows:

    

Three Months Ended September 30, 

2022

    

2023

Total interest and other expense, net presented in the condensed consolidated statements of operations in which the effects of cash flow hedges are recorded

$

(3,432)

$

(5,748)

Gain recognized in other comprehensive income, net of tax

 

3,540

 

1,147

Benefit (expense) reclassified from accumulated other comprehensive income to interest expense, net

 

(120)

 

872

Recent Accounting Pronouncements

From time to time, new accounting pronouncements are issued by the FASB and other regulatory bodies that are adopted as of the specified effective dates. Unless otherwise discussed, management believes that the impact of recently issued standards, which are not yet effective, will not have a material impact on our Consolidated Financial Statements upon adoption. There were no new pronouncements adopted in the first quarter of fiscal year 2024.

2. Business Combinations

Under Accounting Standards Codification Topic 805, Business Combinations (“ASC 805"), the acquisition method of accounting requires us to record assets acquired less liabilities assumed from an acquisition at their estimated fair values at the date of acquisition. Any excess of the total estimated purchase price over the estimated fair value of the net assets acquired should be recorded as goodwill. Such valuations require management to make significant estimates and assumptions, especially with respect to intangible assets. Significant estimates in valuing certain intangible assets include, but are not limited to, future expected cash flows from acquired customers, acquired technology, trade names, useful lives and discount rates. Management’s estimates of fair value are based upon assumptions which are believed to be reasonable, but which are inherently uncertain and unpredictable and, as a result, actual results may differ from estimates. During the measurement period, which is up to one year from the acquisition date, as additional information that existed at the acquisition date becomes available for preliminary estimates, we may record adjustments to the preliminary assets acquired and liabilities assumed. Upon the conclusion of the measurement period, any subsequent adjustments are included in earnings.

Fiscal Year 2024 Business Acquisition

In October 2023, we (through our Security Division) acquired a privately held provider of radiation detection technology for approximately $2.8 million, plus up to $3.6 million in potential contingent consideration.  The acquisition was financed with cash on hand.

The goodwill recognized for this business acquisition is not deductible for income tax purposes.

Fiscal Year 2023 Business Acquisitions

In April 2023, we (through our Optoelectronics and Manufacturing division) acquired a privately held provider of engineering and contract manufacturing solutions for approximately $2.5 million, plus up to $2.5 million in potential contingent consideration. The acquisition was financed with cash on hand.

10

Table of Contents

In February 2023, we (through our Healthcare division) acquired a privately held provider of software and solutions for approximately $2.1 million plus up to $5.0 million in potential contingent consideration. The acquisition was financed with cash on hand.

Through our Security division, we acquired (i) in December 2022 certain assets of a provider of baggage and parcel inspection systems for approximately $1.6 million and (ii) in August 2022 a privately held provider of training software and solutions for approximately $1.9 million plus an immaterial amount of potential contingent consideration. These acquisitions were financed with cash on hand.

The goodwill recognized for each of the fiscal year 2023 business acquisitions is not deductible for income tax purposes. These business acquisitions in fiscal 2023 and 2024, individually and in the aggregate, were not material to our consolidated financial statements. Accordingly, pro-forma historical results of operations and other disclosures related to these businesses have not been presented.

3. Balance Sheet Details

The following tables set forth details of selected balance sheet accounts (in thousands):

June 30, 

September 30, 

Accounts receivable, net

    

2023

    

2023

Accounts receivable

$

395,218

$

337,365

Less allowance for doubtful accounts

 

(14,373)

 

(13,596)

Total

$

380,845

$

323,769

June 30, 

September 30, 

Inventories

    

2023

    

2023

Raw materials

$

233,217

$

271,449

Work-in-process

 

56,329

 

82,969

Finished goods

 

48,462

 

64,379

Total

$

338,008

$

418,797

June 30, 

September 30, 

Property and equipment, net

    

2023

    

2023

Land

$

15,691

$

15,663

Buildings, civil works and improvements

 

49,166

 

48,564

Leasehold improvements

 

13,553

 

13,533

Equipment and tooling

 

135,703

 

136,399

Furniture and fixtures

 

3,632

 

3,241

Computer equipment

 

24,119

 

21,229

Computer software

 

26,981

 

27,487

Computer software implementation in process

9,705

9,544

Construction in process

 

4,108

 

5,806

Total

 

282,658

 

281,466

Less accumulated depreciation and amortization

 

(173,725)

 

(172,292)

Property and equipment, net

$

108,933

$

109,174

Depreciation and amortization expense for property and equipment was $4.9 million in each of the three months ended September 30, 2022 and 2023.

11

Table of Contents

4. Goodwill and Intangible Assets

The changes in the carrying value of goodwill by segment for the three-month period ended September 30, 2023 were as follows (in thousands):

Optoelectronics

And

Security

Healthcare

Manufacturing

    

Division

    

Division

    

Division

    

Consolidated

Balance as of June 30, 2023

$

230,662

$

48,455

$

70,388

$

349,505

Foreign currency translation adjustment

 

(132)

(103)

(859)

(1,094)

Balance as of September 30, 2023

$

230,530

48,352

69,529

348,411

Intangible assets consisted of the following (in thousands):

June 30, 2023

September 30, 2023

Weighted

Gross

Gross

Average

Carrying

Accumulated

Intangibles

Carrying

Accumulated

Intangibles

    

Lives

    

Value

    

Amortization

    

Net

    

Value

    

Amortization

    

Net

Amortizable assets:

Software development costs

 

8-9 years

$

77,844

$

(20,285)

$

57,559

81,845

(21,145)

60,700

Patents

 

19 years

 

8,636

 

(3,404)

 

5,232

8,742

(3,515)

5,227

Developed technology

 

10 years

 

68,274

 

(38,353)

 

29,921

68,246

(40,186)

28,060

Customer relationships

 

7 years

 

55,780

 

(39,101)

 

16,679

55,570

(40,833)

14,737

Total amortizable assets

 

210,534

(101,143)

109,391

214,403

(105,679)

108,724

Non-amortizable assets:

In-process R&D

533

533

533

533

Trademarks

 

30,933

30,933

30,954

30,954

Total intangible assets

$

242,000

$

(101,143)

$

140,857

245,890

(105,679)

140,211

Amortization expense related to intangible assets was $4.7 million in each of the three months ended September 30, 2022 and 2023.

At September 30, 2023, the estimated future amortization expense for amortizable intangible assets was as follows (in thousands):

Fiscal Year

2024 (remaining 9 months)

    

$

14,187

2025

 

15,879

2026

 

12,705

2027

8,741

2028

5,953

Thereafter

 

51,259

Total

$

108,724

Software development costs for software products incurred before establishing technological feasibility are charged to operations. Software development costs incurred after establishing technological feasibility are capitalized on a product-by-product basis until the product is available for general release to customers at which time amortization begins. Annual amortization, charged to cost of goods sold, is the amount computed using the ratio that current revenues for a product bear to the total current and anticipated future revenues for that product. In the event that future revenues are not estimable, such costs are amortized on a straight-line basis over the remaining estimated economic life of the product. Amortizable assets that have not yet begun to be amortized are included in Thereafter in the table above. For the three months ended September 30, 2022 and 2023, we capitalized software development costs in the amounts of $3.9 million and $4.0 million, respectively.

12

Table of Contents

5. Contract Assets and Liabilities

We enter into contracts to sell products and provide services, and we recognize contract assets and liabilities that arise from these transactions. We recognize revenue and corresponding accounts receivable according to ASC Topic 606, Revenue from Contracts with Customers (“ASC 606”). When we recognize revenue in advance of the point in time at which contracts give us the right to invoice a customer, we record this as unbilled revenue, which is included in accounts receivable, net, on the consolidated balance sheets. We may also receive consideration, per the terms of a contract, from customers prior to transferring control of goods to the customer. We record customer deposits as contract liabilities. Additionally, we may receive payments, most typically under service and warranty contracts, at the onset of the contract and before services have been performed. In such instances, we record a deferred revenue liability in either Other accrued expenses and current liabilities or Other long-term liabilities. We recognize these contract liabilities as sales after all revenue recognition criteria are met.

The table below shows the balance of contract assets and liabilities as of June 30, 2023 and September 30, 2023, including the change between the periods. There were no substantial non-current contract assets for the periods presented.

Contract Assets (in thousands)

    

June 30, 

    

September 30, 

    

    

 

    

2023

    

2023

    

Change

    

% Change

 

Unbilled revenue (included in accounts receivable, net)

$

86,818

$

103,663

$

16,845

19

%

Contract Liabilities (in thousands)

    

June 30, 

    

September 30, 

    

    

 

    

2023

    

2023

    

Change

    

% Change

Advances from customers

$

21,250

$

31,949

$

10,699

50

%

Deferred revenue—current

 

43,861

39,000

(4,861)

(11)

%

Deferred revenue—long-term

 

22,200

19,733

(2,467)

(11)

%

Contract assets increased during the three months ended September 30, 2023 primarily from the timing and nature of milestones met in contracts for a number of customers in our Security Division where we met the revenue recognition criteria under ASC 606 in advance of the time when contracts give us the right to invoice customers.

Remaining Performance Obligations. Remaining performance obligations related to ASC 606 represent the portion of the transaction price allocated to performance obligations under an original contract with a term greater than one year which are fully or partially unsatisfied at the end of the period. As of September 30, 2023, the portion of the transaction price allocated to remaining performance obligations was approximately $906.2 million. We expect to recognize revenue on approximately 67% of the remaining performance obligations over the next 12 months, and the remainder is expected to be recognized thereafter. During the three months ended September 30, 2023, we recognized revenue of $29.7 million from contract liabilities existing at the beginning of the period.

Practical Expedients. In cases where we are responsible for shipping after the customer has obtained control of the goods, we have elected to treat the shipping activities as fulfillment activities rather than as a separate performance obligation. Additionally, we have elected to capitalize the cost to obtain a contract only if the period of amortization would be longer than one year. We only give consideration to whether a customer agreement has a financing component if the period of time between transfer of goods and services and customer payment is greater than one year.

13

Table of Contents

6. Leases

The components of operating lease expense were as follows (in thousands):

Three Months Ended September 30, 

    

2022

    

2023

Operating lease cost

$

2,826

$

2,805

Variable lease cost

406

265

Short-term lease cost

223

325

$

3,455

$

3,395

Supplemental disclosures related to operating leases were as follows (in thousands):

    

Balance Sheet Category

    

June 30, 2023

    

September 30, 2023

Operating lease right of use (“ROU”) assets, net

 

Other assets

$

32,618

$

32,534

Operating lease liabilities, current portion

 

Other accrued expenses and current liabilities

$

9,787

$

9,929

Operating lease liabilities, long-term

 

Other long-term liabilities

 

23,733

 

23,472

Total operating lease liabilities

$

33,520

$

33,401

Weighted average remaining lease term

 

 

4.0 years

Weighted average discount rate

 

 

3.9

%

Supplemental cash flow information related to operating leases was as follows (in thousands):

    

Three Months Ended September 30, 

    

2022

    

2023

Cash paid for operating lease liabilities

$

2,685

$

2,994

ROU assets obtained in exchange for new lease obligations

 

413

1,791

Maturities of operating lease liabilities at September 30, 2023 were as follows (in thousands):

    

September 30, 2023

Less than one year

$

11,008

1 – 2 years

 

8,845

2 – 3 years

 

7,664

3 – 4 years

 

5,357

4 – 5 years

 

1,282

Thereafter

 

1,969

 

36,125

Less: imputed interest

 

(2,724)

Total lease liabilities

$

33,401

7. Impairment, Restructuring and Other Charges

We endeavor to align our global capacity and infrastructure with demand by our customers as well as fully integrate acquisitions and thereby improve operational efficiency.

During the three months ended September 30, 2023, we recognized $0.5 million in impairment, restructuring and other charges, which included $0.1 million in legal charges, $0.1 million for employee terminations, $0.1 million for other facility closure costs for operational efficiency activities, and $0.2 million in acquisition related costs.

14

Table of Contents

During the three months ended September 30, 2022, we recognized $1.2 million in restructuring and other charges, which included $0.9 million in legal charges and $0.3 million for employee terminations.

The following tables summarize impairment, restructuring and other charges (benefits), net for the periods set forth below (in thousands):

Three Months Ended September 30, 2022

    

    

    

Optoelectronics and

    

    

Healthcare

Manufacturing

    

Security Division

    

Division

    

Division

    

Corporate

    

Total

Employee termination costs

$

23

$

$

$

$

23

Facility closures/consolidation

241

15

256

Legal costs, net

 

524

294

122

940

Total

$

788

$

294

$

15

$

122

$

1,219

Three Months Ended September 30, 2023

Optoelectronics and

Healthcare